Fundz
Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

LEO Pharma Enters Agreement to Acquire Worldwide Rights to Dersimelagon from Tanabe Pharma for Up to $435 Million.

Aug 18, 2026•about 3 hours ago

Contract Type

agreement

New JerseyBiotechnologyHealth CareMedical

Description

LEO Pharma has announced an agreement to acquire the worldwide rights to dersimelagon, a novel treatment for rare genetic diseases, from Tanabe Pharma. The deal involves committed payments of up to $435 million, subject to regulatory approvals.

Company Information

Company

LEO Pharma

Location

New Jersey, United States

About

LEO Pharma Inc. is a global leader in medical dermatology, dedicated to improving patient outcomes in skin disease. The company focuses on developing treatments and raising awareness for various skin conditions, including chronic hand eczema. LEO Pharma emphasizes the importance of patient voice in healthcare and aims to enhance the standard of care for patients living with skin diseases. Their newly launched 'Talk to the Hand' campaign seeks to educate healthcare providers on the impact of chronic hand eczema.

Predictive Intelligence
Strategic

ML-powered predictions for LEO Pharma's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.